jsmc-10163

PREVALENCE OF VITAMIN D DEFICIENCY AMONG PATIENTS WITH OBSTRUCTIVE LUNG DISEASES (ASTHMA, COPD, BRONCHIECTASIS) IN SULAIMANI

Kamaran Amin Omer Karadakhy a and Chrakhan Mohammed Haji b

a Department of Medicine, College of Medicine, University of Sulaimani. 

b Kurdistan Board of Medical Specialties Candidate.

Submitted: 18/4/2018; Accepted: 25/7/2018; Published 15/10/2018

DOI Link: https://doi.org/10.17656/jsmc.10163 

ABSTRACT

Background 

Role of vitamin D in respiratory diseases is still need to be addressed. Literatures showed lower levels of vitamin D was associated with a reduction of lung function assessed by FEV1 and FVC in normal subjects.

Objectives 

To assess the vitamin D level in patients with obstructive pulmonary diseases and matched controls, and to study the variability in vitamin D level with obstructive pulmonary disease characteristics.

Materials and Methods

A total of 102 cases with Obstructive Pulmonary Disease were enrolled and 127 healthy subjects as a control group. History taking, respiratory questionnaire, spirometry, chest CT scan and chest X-Ray had been used in the diagnosis. Patients with thyroid function disorder, vitamin D user, and bad compliance were excluded. Waters CE-Marks in Vitro Diagnostic Mass Trak Vitamin D Solution was used to determine the level of vitamin D in both groups. Lab values in ng/ml; Deficiency (<20 ng/ml), Insufficiency (20-29 ng\ml) and Sufficiency (30-100 ng\ml).

Results

All the data from both enrolled and control group were entered and analyzed using statistical package for social science (SPSS) version 20. From 102 cases two cases within normal value (1.7%), 88 cases (86.3%) Deficiency <20 ng/ml, 12 cases (11.8%) Insufficiency (20-29) ng/ml. Totally 100 cases (98.3 %) had low Vitamin D. The prevalence of low Vitamin D level in asthma was 96.3 %, Chronic Obstructive Pulmonary Disease 100%, and bronchiectasis 100 %. Both age and smoking habit had a statistically significant relationship with Vitamin D level. 

Conclusion

The prevalence of low Vitamin D is very high in both patients and health group (98.3 % and 85.8%). Chronic ObstructivePulmonary Disease and bronchiectasis were 100% and asthma cases were 96.3%. Both age and smoking habit had a significant effect on Vitamin D level. Undiagnosed Chronic Obstructive Pumonary Disease was a big challenge in our study. We will recommend the parallel process of the diagnosis and screening for both ObstructivePulmonary Disease and Vitamin D level.

KEYWORDS

Vitamin D deficiency and insufficiency, Obstructive Pulmonary Diseases.

References 

1. Anthony W.Norman. History of Vitamin D. Historical review, University of California, Nov.2011.

2. Dunn PM. Francis Glisson (1597–1677) and the “discovery” of rickets. Archives of Disease in Childhood-Fetal and Neonatal Edition. 1998 Mar 1; 78(2): F154-5.

3. Mallard SR, Howe AS, Houghton LA. Vitamin D status and weight loss: a systematic review and meta-analysis of randomized and nonrandomized controlled weight-loss trials, 2. The American journal of clinical nutrition. 2016 Sep 7;104(4):1151-9.

4. Bischoff-Ferrari HA. Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes. InSunlight, Vitamin D and Skin Cancer 2014 (pp. 500-525). Springer, New York, NY.

5. Murray CJ, Lopez AD.. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349(9063):1436-42. 

6. Pludowski P, Holick MF, Grant WB, Konstantynowicz J, Mascarenhas MR, Haq A, Povoroznyuk V, Balatska N, Barbosa AP, Karonova T, Rudenka E. Vitamin D supplementation guidelines. The Journal of steroid biochemistry and molecular biology. 2018 Jan 1;175: 125-35.

7. Khan DM, Ullah A, Randhawa FA, Iqtadar S, Butt NF, Waheed K. Role of Vitamin D in reducing number of acute exacerbations in Chronic Obstructive Pulmonary Disease (COPD) patients. Pakistan journal of medical sciences. 2017 May;33(3):610.

8. Holick MF. High prevalence of vitamin D inadequacy and implications for health. InMayo Clinic Proceedings 2006 Mar 1 (Vol. 81, No. 3, pp. 353-373). Elsevier.

9. Yoon HeeKim, Kyung Won Kim, Min Jung Kim, In-Suk Sol, SeoHeeYoon, HyeongSikAhn, Hyun Jung Kim, Myung Hyun Sohn, Kyu-Earn Kim.Vitamin D levels in allergic rhinitis: a systematic review and meta-analysis; Pediatric Allergy and ImmunologyVolume 27, Issue 6, 21 JUN 2016; 

10. Vichyanond P, Jirapongsananuruk O, Visitsuntorn N, Tuchinda M. Prevalence of asthma, rhinitis and eczema in children from the Bangkok area using the ISAAC (International Study for Asthma and Allergy in Children) questionnaires. Journal of the Medical Association of Thailand= Chotmaihet thangphaet. 1998 Mar;81(3):175-84.

11. Odler B, Ivancsó I, Somogyi V, Benke K, Tamási L, Gálffy G, Szalay B, Müller V. Vitamin D deficiency is associated with impaired disease control in asthma–COPD overlap syndrome patients. International journal of chronic obstructive pulmonary disease. 2015;10: 2017.

12. Barrecheguren M, Esquinas C, Miravitlles M. The asthma–chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges. Current opinion in pulmonary medicine. 2015 Jan 1;21(1):74-9.

13.  Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB, Weiss ST. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys J Allergy Clin Immunol. 2004 Jul;114(1):40-7

14.  Søren Perersen. Helen K reddel. Others Global Initiative for Asthma,GI NA guideline, 2017 report.

15. Alvar Agusti. Claus Vogelmeier. Rebbecca Decker.Others.GOLD-COPD guideline 2018 report.

16. Herrera AC, de Oca MM, Varela MV, Aguirre C, Schiavi E, Jardim JR, PUMA Team. COPD underdiagnosis and misdiagnosis in a high-risk primary care population in four Latin American countries. A key to enhance disease diagnosis: the PUMA study. PloS one. 2016 Apr 13;11(4): e0152266.

17. Lamprecht B, Soriano JB, Studnicka M, Kaiser B, Vanfleteren LE, Gnatiuc L, Burney P ,Miravitlles M, García-Rio F, Akbari K, Ancochea J, Menezes AM, Perez-Padilla R, Montes de Oca M, Torres-Duque CA, Caballero A, González-García M. Buist SDeterminants of under diagnosis of COPD in national and international surveys. Chest. 2015 Oct;148(4):971-985

18. Miravitlles M, Soriano JB, Garcia-Rio F, Muñoz L, Duran-Tauleria E, Sanchez G, Sobradillo V, Ancochea J. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009 Jun 23.

19. Baran Ezequiel, Relationship between Vitamin D and severity in COPD patients. EMJ Respir. 2017;5[1]:59-60.

20. Mekov E, Slavova Y, Tsakova A, Genova M, Kostadinov D, Minchev D, Marinova D, Tafradjiiska M. Vitamin D status in COPD patients admitted for exacerbation.

21. Yangui F, Melki B, Abouda M, Triki M, Charfi MR. Clinical impact of vitamin D deficiency on Tunisian asthmatics. European Respiratory Journal 2017 50: PA3996; DOI: 10.1183/1393003.

22. Hollams EM, Hart PH, Holt BJ, Serralha M, Parsons F, De Klerk NH, Zhang G, Sly PD, Holt PG. Vitamin D and atopy and asthma phenotypes in children: a longitudinal cohort study. European Respiratory Journal. 2011 Jan 1: erj00290-2011.

23. Chalmers JD, McHugh BJ, Docherty C, Govan JR, Hill AT. Vitamin-D deficiency is associated with chronic bacterial colonisation and disease severity in bronchiectasis. Thorax. 2012 Oct 1: thoraxjnl-2012.

24. MichelaBellocchia , Monica Masoero, Arianna Vaudano, Antonio Ciuffreda, Andrei Malinovschi, CaterinaBucca. Vitamin D, exacerbations and hospitalizations in COPD patients; European Respiratory Society Annual Congress 2013. 42: P1530; An.591

Full Text

 © The Authors, published by University of Sulaimani, College of Medicine

This work is licensed under a Creative Commons Attribution 4.0 International License.